JCAR017-EAP-001: Expanded Access Protocol (EAP) for Subjects Receiving Lisocabtagene Maraleucel that is Nonconforming for Commercial Release

Title
Expanded Access Protocol (EAP) for Subjects Receiving Lisocabtagene Maraleucel that is Nonconforming for Commercial Release
Principal Investigator
Veltri, Lauren
Phase
NA
Age Group
Adult
Applicable Disease Sites
Leukemia
Lymphoma
Multiple Myeloma
Participating Institutions
Mary Babb Randolph Cancer Center
Contacts
Crystal Peck, RN
BMT Coordinator
Phone: +1 304-598-4500
Email:

View on ClinicalTrials.gov